In-Person Access Only | 7.00 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
We invite you to join us for the Best of Hematology conference in Portsmouth, NH happening simultaneously with the 4th Annual Best of Hematology in Vail, CO. This innovative and state of the art program will feature some of the world's leading hematologists to present the latest research and strategies for the care of hematological malignancies — incorporating data from the major oncologic annual meetings.
Conference Agenda
Saturday, February 6, 2027
Program Chairs:
Hamza Hasmi, MD | Memorial Sloan Kettering Cancer Center
Frederick Lansigan, MD | Dartmouth Health
7:15 AM - 7:45 AM
Coffee and Registration
7:45 AM - 8:15 AM
Breakfast and Exhibits
8:15 AM - 9:00 AM
Non-CME Breakfast - Pfizer ACEDTRIS
9:00 AM - 9:20 AM
Coffee Break and Networking
9:20 AM - 9:30 AM
Welcome and Opening Remarks
9:30 AM - 10:00 AM
Acute Leukemias in 2027: MRD-Guided Therapy, Cellular Immunotherapy, and Emerging Treatment Strategies in AML and ALL
Evan Chen, MD | Dana-Farber Cancer Institute
10:00 AM - 10:30 AM
CLL: Fixed-Duration Therapy, BTK Degraders, and Treatment Sequencing
Frederick Lansigan, MD | Dartmouth Health
10:30 AM - 10:40 AM
Coffee Break and Networking
10:40 AM - 11:10 AM
DLBCL Beyond R-CHOP: How Are Bispecifics and CAR-T Moving Earlier?
Hari Raman, MD, MBA | Dana-Farber Cancer Institute
11:10 AM - 11:40 AM
Follicular and Indolent Lymphomas: When to Use Bispecifics, CAR-T, and Novel Immune Therapies
Anne Beaven, MD | UNC
11:40 AM - 12:10 PM
Sickle Cell Disease
Scott Peslak, MD, PhD | Penn Medicine
12:10 PM - 12:20 PM
Housekeeping and Survey
12:20 PM - 12:40 PM
Lunch and Exhibits
12:40 PM - 1:25 PM
Non-CME Lunch
1:25 PM - 1:55 PM
Coffee Break and Networking
1:55 PM - 2:55 PM
Extended Panel Discussion: Practice-Changing Hematology Abstracts 2026-2027: What Will Change Monday Morning?
Frederick Lansigan, MD | Dartmouth Health (Moderator)
Anne Beaven, MD | UNC
Scott Peslak, MD, PhD | Penn Medicine
Evan Chen, MD | Dana-Farber Cancer Institute
Hari Raman, MD, MBA | Dana-Farber Cancer Institute
2:55 PM
ADJOURN
Sunday, February 7, 2027
7:15 AM - 7:45 AM
Coffee and Registration
7:45 AM - 8:15 AM
Breakfast and Exhibits
8:15 AM - 9:00 AM
Non-CME Breakfast - Pfizer ELREXFIO
9:00 AM - 9:20 AM
Coffee Break and Networking
9:20 AM - 9:30 AM
Welcome and Opening Remarks
9:30 AM - 10:00 AM
Multiple Myeloma: Sequencing BCMA and GPRC5D Therapies in Clinical Practice
Hamza Hashmi, MD | Memorial Sloan Kettering Cancer Center
10:00 AM - 10:30 AM
Time-Limited Maintenance: Is Continuous Therapy Still the Standard?
10:30 AM - 10:40 AM
Coffee Break and Networking
10:40 AM - 11:10 AM
MDS and MPNs: New Standards of Care and Emerging Disease-Modifying Strategies
Shyam Patel, MD, PhD | U Mass Medicine
11:10 AM - 11:40 AM
Benign Hematology in 2027: Advances in Thrombosis, Anticoagulation, and Bleeding Disorders
11:40 AM - 12:10 PM
Navigating Rare Lymphoid Malignancies: Current Approaches to PTLD, CNS Lymphomas, and HIV-Related Lymphomas
Nina Wagner-Johnston, MD | Johns Hopkins Medicine
12:10 PM - 12:20 PM
Housekeeping and Survey
12:20 PM - 12:40 PM
Lunch and Exhibits
12:40 PM - 1:25 PM
Non-CME Lunch
1:25 PM - 1:55 PM
Coffee Break and Networking
1:55 PM - 2:55 PM
Extended Panel Discussion: How Are You Actually Integrating Novel Hematology Therapies Into Practice?
Hamza Hashmi, MD | Memorial Sloan Kettering Cancer Center (Moderator)
Nina Wagner-Johnston, MD | Johns Hopkins Medicine
Shyam Patel, MD, PhD | U Mass Medicine
2:55 PM
ADJOURN
Agenda Subject To Change. All times are EST.
-
Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various hematologic malignancies.
Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with hematologic malignancies.
Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with hematologic malignancies.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of TBD ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of TBD AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of TBD knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to TBD Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program